Open | $3.790 |
Close | $4.410 |
Volume / Avg. | 632.684K / 854.167K |
Day Range | 3.700 - 4.530 |
52 Wk Range | 0.360 - 6.040 |
Market Cap | $376.335M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 63 |
Short Interest | 2.65% |
Days to Cover | 1.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ADC Therapeutics (NYSE: ADCT) through any online brokerage.
There are no as such competitors for ADC Therapeutics.
The latest price target for ADC Therapeutics (NYSE: ADCT) was reported by RBC Capital on Thursday, March 14, 2024. The analyst firm set a price target for 8.00 expecting ADCT to rise to within 12 months (a possible 75.44% upside). 16 analyst firms have reported ratings in the last year.
The stock price for ADC Therapeutics (NYSE: ADCT) is $4.56 last updated March 18, 2024 at 7:50 PM EDT.
There are no upcoming dividends for ADC Therapeutics.
ADC Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for ADC Therapeutics.
ADC Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NYSE.